118
Views
33
CrossRef citations to date
0
Altmetric
Review

Gene delivery using cationic liposomes

&
Pages 1371-1382 | Published online: 04 Oct 2006

Bibliography

  • FELGNER PL, GADEK TR, HOLM M et al.: Lipofection: a highly efficient, lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. USA (1987) 84:7413-7417.
  • BRIGHAM KL, MEYRICK B, CHRISTMAN B et al.: In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am. J. Med. Sci. (1989) 298(4):278-281.
  • GHOSH YK, VISWESWARIAH S, BHATTACHARYA S: Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency. FEBS Lett. (2000) 473:341-344.
  • PATIL SD, RHODES DG, BURGESS DJ: Biophysical characterization of anionic lipoplexes. Biochim. Biophys. Acta (2005) 1711:1-11.
  • PEYRE M, AUDRAN R, ESTEVEZ F et al.: Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions. J. Control. Release (2004) 99:345-355.
  • RAO M, ALVING CR: Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. Ad. Drug Deliv. Rev. (2000) 41:171-188.
  • ZALLEN DT: US gene therapy in crisis. Trends Genet. (2000) 16:272-275.
  • LUO D, SALTZMAN WM: Synthetic DNA delivery systems. Nat. Biotechnol. (2000) 18(1):33-37.
  • MERDAN T, KOPECEK J, KISSEL T: Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Ad. Drug Deliv. Rev. (2002) 54(5):715-758.
  • KICHLER A, MECHTLER K, BEHR JP, WAGNER E: Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer. Bioconjug. Chem. (1997) 8(2):213-221.
  • GREGORIADIS G: The carrier potential of liposomes in biology and medicine (second of two parts). N. Engl. J. Med. (1976) 295(14):765-770.
  • LINDER LH, BROCK R, ARNDT-JOVIN D, EIBL H: Structural variation of cationic lipids: minimum requirement for improved oligonucleotide delivery into cells. J. Control. Release (2006) 110:444-456.
  • MANNINO RJ AE, STROHL WA: Encapsulation of high molecular weight DNA in large unilamellar phospholipid vesicles. Dependence on the size of the DNA. FEBS Lett. (1979) 101:229-232.
  • MAY S, HARRIES D, BEN-SHAUL A: The phase behaviour of cationic lipid-DNA complexes. Biophys. J. (2000) 78:1681-1697.
  • PEDROSO DE LIMA MC, SIMÕES S, PIRES P, FANECA H, DÜZGÜNES N: Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Ad. Drug Deliv. Rev. (2001) 47:277-294.
  • BENNETT CF, MIREJOVSKY D, CROOKE RM et al.: Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture. J. Drug Target. (1998) 5(3):149-162.
  • ILIES MA, BALABAN AT: Recent developments in cationic lipid-mediated gene delivery and gene therapy. Expert Opin. Ther. Patents (2001) 11(11):1729-1752.
  • ELOUAHABI A, RUYSSCHAERT J-M: Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther. (2004) 11:336-347.
  • FARHOOD H, BOTTEGA R, EPAND RM, HUANG L: Effect of cationic cholesterol deriviatives on gene-transfer and PKC activity. Biochim. Biophys. Acta. (1992) 1111:239-246.
  • FLETCHER S, AHMAD A, PEROUZEL E, HERON A, MILLER AD, JORGENSEN MR: In vivo studies of dialkynoyl analogues of DOTAP demonstrate improved gene transfer efficiency of cationic liposomes in mouse lung. J. Med. Chem. (2006) 49(1):349-357.
  • GAO X, HUANG L: A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. (1991) 179:280-285.
  • KICHLER A, LEBORGNE C, SAVAGE PB, DANOS O: Cationic steroid antibiotics demonstrate DNA delivery properties. J. Control. Release (2005) 107:174-182.
  • FARHOOD H, SERBINA N, HUANG L: The role of dioleoyl phosphatidyl- ethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta (1995) 1235:289-295.
  • CONNER J, HUANG L: pH-Sensitive immunoliposomes as an efficient and target specific carrier for antitumour drugs. Cancer Res. (1986) 46:3431-3435.
  • ELLENS H, BENTZ J, SZOKA FC: pH-Induced destabilisation of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry (1984) 23:1532-1538.
  • BURGER KNJ, VERKLEY AJ: Membrane-fusion. Experimentia (1990) 46:631-644.
  • CULLIS PR, HOPE MJ, TILCOCK CP: Lipid polymorphism and the roles of lipid membranes. Chem. Phys. Lipids (1986) 40:127-144.
  • HEYES J, PALMER L, BREMNER K, MACLACHLAN I: Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J. Control. Release (2005) 107:276-287.
  • SANKARAM MB, POWELL GL, MARSH D: Effect of acyl chain composition on salt-induced lamellar to inverted hexagonal phase transitions in cardiolipin. Biochim. Biophys. Acta. (1989) 980(3):389-392.
  • CONGIU A, POZZI D, ESPOSITO C, CASTELLANO C, MOSSA G: Correlation between structure and transfection efficiency: a study of DC-Chol- DOPE/DNA complexes. Colloids Surf. B. Biointerfaces (2004) 36:43-48.
  • HIRSCH-LERNER D, ZHANG M, ELIYAHU H et al.: Effect of "helper lipid" on lipoplex electrostatics. Biochim. Biophys. Acta. (2005) 1714(2):71-84.
  • STERNBERG B, SORGI FL, HUANG L: New structures in complex formulation between DNA and cationic liposomes visualized by freeze-fracture electron microscope. FEBS Lett. (1994) 356:361-366.
  • TEMPLETON NS, LASIC DD, FREDRICK PM, STREY H, ROBERTS DD, PAVLAKIS GN: Improved DNA: liposome complexes for increased systematic delivery and gene expression. Nat. Biotechnol. (1997) 15:647-652.
  • FILION MC, PHILLIPS NC: Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim. Biophys. Acta. (1997) 1329:345-356.
  • WAGNER E: Application of membrane-active peptides for nonviral gene delivery. Adv. Drug Deliv. Rev. (1999) 38(3):279-289.
  • KAMATA H, YAGISAWA H, TAKAHASHI S, HIRATA H: Amphiphilic peptides enhance the efficiency of liposome-mediated DNA transfection. Nucleic Acids Res. (1994) 22(3):536-537.
  • KIRCHEIS R, KICHLER A, WALLNER G et al.: Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. (1997) 4(5):409-418.
  • DEAN DA, STRONG DD, ZIMMER WE: Nuclear entry of nonviral vectors. Gene Ther. (2005) 12(11):881-890.
  • ALMOFTI MR, HARASHIMA H, SHINOHARA Y, ALMOFTI A, BADA Y, KIWADA H: Cationic liposome-mediated gene delivery: Biophysical study and mechanism of internalization. Arch. Biochem. Biophys. (2003) 410:246-253.
  • BIRCHALL JC, KELLAWAY IW, MILLS SN: Physio-chemical characterization and transfection efficiency of lipid-based gene delivery complexes. Int. J. Pharm. (1999) 183:195-207.
  • EWERT K, EVANS HM, AHMAD A et al: Lipoplex structures and their distinct cellular pathways. Adv. Genet. (2005) 53:119-155.
  • BALLY MB, HARVIE P, WONG FM, KONG S, WASAN EK, REIMER DL: Biological barriers to cellular delivery of lipid-based DNA carriers. Ad. Drug Deliv. Rev. (1999) 38:291-315.
  • EASTMAN SJ, SIEGEL C, TOUSIGNANT J, SMITH AE, CHENG SH, SCHEULE RK: Biophysical characterization of cationic lipid:DNA complexes. Biochim. Biophys. Acta. (1997) 1325:41-62.
  • FANECA H, SIMÕES S, PEDROSO DE LIMA MC: Evaluation of lipid-based reagents to mediate intracellular gene delivery. Biochim. Biophys. Acta. (2002) 1567:23-33.
  • ZHANG Y, ANCHORDOQUY TJ: The role of lipid charge density in the serum stability of cationic lipid/DNA complexes. Biochim. Biophys. Acta. (2004) 1663:143-157.
  • GREGORIADIS G, DAVIS C: Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem. Biophys. Res. Commun. (1979) 89:1287-1293.
  • ALLEN TM, HANSEN C, MARTIN F, REDEMANN C, YAU-YOUNG A: Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta. (1991) 1066(1):29-36.
  • MAHATO RI, KAWABATA K, TAKAKUR Y, HASHIDA M: In vivo dipositition characteristics of plasmid DNA complexed with cationic liposomes. J. Drug Target. (1995) 3:149-157.
  • LEW D, PARKER S, LATIMER T et al.: Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Human Gene Ther. (1995) 6:553-564.
  • LI S, TSENG WC, WHITMORE M et al.: Lipidic vectors for intravenous gene delivery. J. Liposome Res. (1998) 8:18-20.
  • LIU Y, LIGGIT D, ZHONG W, TU G, GAENSLER K, DEBS R: Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. (1995) 270:24864-24870.
  • SONG YK, LIU DX: Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration. Biochim. Biophys. Acta. (1998) 1372:141-150.
  • THIERRY AR, LUNARDI-ISKANDAR Y, RABINOVICH P, GALLO RC, MAHAN LC: Systemic gene therapy: biodistribution and long term expression of a transgene in mice. Proc. Nat. Acad. Sci. USA (1995) 92:9742-9746.
  • BARU M, NAHUM O, JAARO H, SHA'ANANI J, NUR I: Lysosome-disrupting peptide increases the efficiency of in vivo gene transfer by liposome-encapsulated DNA. J. Drug Target. (1998) 6(3):191-199.
  • ELIYAHU H, SERVEL N, DOMB AJ, BARENHOLZ Y: Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery. Gene Ther. (2002) 9(13):850-858.
  • ZHANG Y, SCHLACHETZKI F, PARDRIDGE WM: Global non-viral gene transfer to the primate brain following intravenous administration. Mol. Ther. (2003) 7(1):11-18.
  • ZHANG Y, SCHLACHETZKI F, PARDRIDGE WM:
  • KHALIL IA, KOGURE K, AKITA H, HARASHIMA H: Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharma. Rev. (2006) 58(1):32-45.
  • BOTTEGA R, EPAND RM: Inhibition of protein kinase C by cationic amphiphiles. Biochemistry (1992) 31(37):9025-9030.
  • VAN DER WOUDE I, WAGENAAR A, MEEKEL AA et al.: Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery. Proc. Natl. Acad. Sci. USA (1997) 94(4):1160-1165.
  • LIU D, HU J, QIAO W et al.: Synthesis and characterization of a series of carbamate-linked cationic lipids for gene delivery. Lipids (2005) 40(8):839-848.
  • SENIOR JH, TRIMBLE KR, MASKIEWICZ R: Interaction of positively-charged liposomes with blood: implications for their application in vivo. Biochim. Biophys. Acta. (1991) 1070(1):173-179.
  • YEW NS, SCHEULE RK: Toxicity of cationic lipid–DNA complexes. Advanced genetics. In: Non-Viral Vectors for Gene Therapy, Second Edition: Part 1. Hung MC, Huang L, Wagner E (Eds). Elsevier, New York (NY) USA (2005):189-214.
  • BAATZ JE, ZOU Y, KORFHAGEN TR: Inhibitory effects of TNF-α on cationic lipid-mediated gene delivery to airway cells in vitro. Biochim. Biophys. Acta. (2001) 1535(2):100-109.
  • CHEN Y, LENERT P, WEERATNA R et al.: Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther. (2001) 8(13):1024-1032.
  • BEHR J: Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. Bioconjug. Chem. (1994) 5:382-389.
  • GAO X, HUANG L: Cationic liposome-mediated gene transfer. Gene Ther. (1995) 2(10):710-722.
  • HOFLAND HE, MASSON C, IGINLA S et al.: Folate-targeted gene transfer in vivo. Mol. Ther. (2002) 5(6):739-744.
  • BLACK CD, GREGORIADIS G: Interaction of liposomes with blood plasma proteins. Biochem. Soc. Trans. (1976) 4(2):253-256.
  • ZELPHATI O, SZOKA FC Jr: Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA (1996) 93(21):11493-11498.
  • PERRIE Y, GREGORIADIS G: Liposome-entrapped plasmid DNA: characterisation studies. Biochim. Biophys. Acta. (2000) 1475:125-132.
  • PERRIE Y, BARRALET JE, MCNEIL S, VANGALA A: Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route. Int. J. Pharm. (2004) 284(1-2):31-41.
  • PERRIE Y, FREDERIK PM, GREGORIADIS G: Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine (2001) 19(23-24):3301-3310.
  • PERRIE Y, MCNEIL S, VANGALA A: Liposome-mediated DNA immunisation via the subcutaneous route. J. Drug Target. (2003) 11(8-10):555-563.
  • PERRIE Y, OBRENOVIC M, MCCARTHY D, GREGORIADIS G: Liposome (lipodine)-mediated DNA vaccination by the oral route. J. Liposome Res. (2002) 12(1-2):185-197.
  • ANDERSEN P: Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. (1994) 62(6):2536-2544.
  • DAVIDSEN J, ROSENKRANDS I, CHRISTENSEN D et al.: Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate) – a novel adjuvant inducing both strong CMI and antibody responses. Biochim. Biophys. Acta. (2005) 1718(1-2):22-31.
  • VANGALA A, KIRBY D, ROSENKRANDS I et al.: A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice. J. Pharm. Pharmacol. (2006) 58(6):787-799.
  • BRAMWELL VW, PERRIE Y: Particulate delivery systems for vaccines. Crit. Rev. Ther. Drug Carrier Syst. (2005) 22(2):151-214.
  • BRUNEL F, DARBOURET A, RONCO J: Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine. Vaccine (1999) 17(17):2192-2203.
  • BRANDT L, ELHAY M, ROSENKRANDS I, LINDBLAD EB, ANDERSEN P: ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. (2000) 68(2):791-795.
  • HOLTEN-ANDERSEN L, DOHERTY TM, KORSHOLM KS, ANDERSEN P: Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines. Infect. Immun. (2004) 72(3):1608-1617.
  • ULMER JB, DONNELLY JJ, PARKER SE et al.: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 259(5102):1745-1749.
  • DE LAPORTE L, CRUZ REA J, SHEA LD: Design of modular non-viral gene therapy vectors. Biomaterials (2006) 27(7):947-954.
  • FELGNER JH, KUMAR R, SRIDHAR CN et al.: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. (1994) 269(4):2550-2561.
  • ROPERT C: Liposomes as a gene delivery system. Braz. J. Med. Biol. Res. (1999) 32(2):163-169.
  • GREGORIADIS G: Liposomes, a tale of drug targeting. J. Drug Target. (1993) 1(1):3-6.
  • HONG K, ZHENG W, BAKER A, PAPAHADJOPOULOS D: Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. (1997) 400(2):233-237.
  • ZALIPSKY S, BRANDEIS E, NEWMAN MS, WOODLE MC: Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine. FEBS Lett. (1994) 353(1):71-74.
  • LEONG KW, MAO HQ, TRUONG-LE VL, ROY K, WALSH SM, AUGUST JT: DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Release (1998) 53(1-3):183-193.
  • POPIELARSKI SR, MISHRA S, DAVIS ME: Structural effects of carbohydrate-containing polycations on gene delivery. 3. Cyclodextrin type and functionalization. Bioconjug. Chem. (2003) 14(3):672-678.
  • HWA KIM S, HOON JEONG J, JOE CO, GWAN PARK T: Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate. J. Controll. Release (2005) 103(3):625-634.
  • OGRIS M, BRUNNER S, SCHÜLLER S, KIRCHEIS R, WAGNER E: Pegylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. (1999) 6(4):595-605.
  • KUNATH K, MERDAN T, HEGENER O, HABERLEIN H, KISSEL T: Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J. Gene Med. (2003) 5(7):588-599.
  • BLESSING T, KURSA M, HOLZHAUSER R, KIRCHEIS R, WAGNER E: Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem. (2001) 12(4):529-537.
  • KIRCHEIS R, KICHLER A, WALLNER G et al.: Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. (1997) 4(5):409-418.
  • HATTORI Y, SUZUKI S, KAWAKAMI S, YAMASHITA F, HASHIDA M: The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J. Control. Release (2005) 108:484-495.
  • HATTORI Y, KAWAKAMI S, NAKAMURA K, YAMASHITA F, HASHIDA M: Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. J. Pharmacol. Exp. Ther. (2006) 2:2.
  • KAWAKAMI S, SATO A, NISHIKAWA M, YAMASHITA F, HASHIDA M: Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. (2000) 7(4):292-299.
  • KAWAKAMI S, YAMASHITA F, NISHIKAWA M, TAKAKURA Y, HASHIDA M: Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem. Biophys. Res. Commun. (1998) 252(1):78-83.

Patents

Websites

  • http://www.wiley.co.uk/genmed/clinical Worldwide gene therapy clinical trials. Accessed 5 June, 2006.
  • http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi PubMed. Accessed 5 June ,2006.
  • http://ep.espacenet.com/ European Patent Office. Accessed 5 June, 2006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.